SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -88.9% | 70 | -87.7% | 0.00% | -87.5% |
| Q1 2022 | $45,000 | -11.8% | 570 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | -48.5% | 570 | -46.7% | 0.01% | -55.6% |
| Q3 2021 | $99,000 | +19.3% | 1,070 | 0.0% | 0.02% | +20.0% |
| Q2 2021 | $83,000 | +3.8% | 1,070 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $80,000 | -18.4% | 1,070 | +85.8% | 0.02% | -28.0% |
| Q4 2020 | $98,000 | +60.7% | 576 | +32.1% | 0.02% | +25.0% |
| Q3 2020 | $61,000 | +60.5% | 436 | +84.7% | 0.02% | +33.3% |
| Q2 2020 | $38,000 | +81.0% | 236 | +11.8% | 0.02% | +50.0% |
| Q1 2020 | $21,000 | +50.0% | 211 | +99.1% | 0.01% | +100.0% |
| Q4 2019 | $14,000 | +75.0% | 106 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $8,000 | -50.0% | 106 | 0.0% | 0.00% | -42.9% |
| Q2 2019 | $16,000 | +1500.0% | 106 | +1666.7% | 0.01% | +600.0% |
| Q1 2019 | $1,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |